U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H18NO2
Molecular Weight 160.234
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of CARPRONIUM

SMILES

COC(=O)CCC[N+](C)(C)C

InChI

InChIKey=XQSLKIBWQSTAGK-UHFFFAOYSA-N
InChI=1S/C8H18NO2/c1-9(2,3)7-5-6-8(10)11-4/h5-7H2,1-4H3/q+1

HIDE SMILES / InChI

Molecular Formula C8H18NO2
Molecular Weight 160.234
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/22171995 and http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1602

Carpronium chloride is a hair growth reagent with a vasodilatory action. In vivo studies indicated that carpronium chloride achieved dilatation of vascular smooth muscle in the microcirculation of rats. FUROZIN SOLUTION 5% (active ingredient Carpronium chloride) has local vasodilating effect and hair growth stimulatory effect to improve alopecia and vitiligo. It is usually used for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
FUROZIN SOLUTION 5%

Approved Use

Used for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris.
Primary
FUROZIN SOLUTION 5%

Approved Use

Used for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris.
Primary
FUROZIN SOLUTION 5%

Approved Use

Used for the prevention of hair loss, for hair growth stimulation, and in the treatment of seborrhea sicca and vitiligo vulgaris.
PubMed

PubMed

TitleDatePubMed
Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice.
2003 Feb
Topical immunotherapy in alopecia areata.
2010 Jan
Patents

Sample Use Guides

For alopecia and seborrhea sicca: In general, apply appropriate amount of the medicine to the affected area; or sprinkle the medicine on the whole scalp; twice to 3 times daily, and gently massage the head. For vitiligo vulgaris: In general, apply appropriate amount of the medicine to the affected area, 3 to 4 times daily.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:08:47 GMT 2023
Edited
by admin
on Fri Dec 15 17:08:47 GMT 2023
Record UNII
X6UK728GLZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CARPRONIUM
WHO-DD  
Common Name English
CARPRONIUM ION
Common Name English
CARPRONIUM CATION
Common Name English
(3-CARBOXYPROPYL)TRIMETHYLAMMONIUM, METHYL ESTER
Common Name English
Carpronium [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C47796
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
Code System Code Type Description
FDA UNII
X6UK728GLZ
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
SMS_ID
100000076283
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
CAS
14075-13-9
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
CHEBI
145653
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
NCI_THESAURUS
C83601
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID8048236
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
EVMPD
SUB13249MIG
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
MESH
C001817
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
DRUG CENTRAL
519
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
PUBCHEM
2582
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY